Arcutis Biotherapeutics director Howard G. Welgus sells 4,730 common shares for $123,835.71 - ARQT News | RalliesArcutis Biotherapeutics director Howard G. Welgus sells 4,730 common shares for $123,835.71
A
ARQT• Director share sale and option exercise
- Arcutis Biotherapeutics director Howard G. Welgus sold 4,730 common shares at $26.18 on Aug. 17.
- He exercised stock options for 4,096 shares at $6.52 to $8.63 on the same day.
- Directly held common shares fell to 36,475 following the transactions.
•
